323 related articles for article (PubMed ID: 34772932)
1. WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells.
Datta A; Biswas K; Sommers JA; Thompson H; Awate S; Nicolae CM; Thakar T; Moldovan GL; Shoemaker RH; Sharan SK; Brosh RM
Nat Commun; 2021 Nov; 12(1):6561. PubMed ID: 34772932
[TBL] [Abstract][Full Text] [Related]
2. WRN rescues replication forks compromised by a BRCA2 deficiency: Predictions for how inhibition of a helicase that suppresses premature aging tilts the balance to fork demise and chromosomal instability in cancer.
Datta A; Brosh RM
Bioessays; 2022 Aug; 44(8):e2200057. PubMed ID: 35751457
[TBL] [Abstract][Full Text] [Related]
3. Cockayne syndrome group B protein regulates fork restart, fork progression and MRE11-dependent fork degradation in BRCA1/2-deficient cells.
Batenburg NL; Mersaoui SY; Walker JR; Coulombe Y; Hammond-Martel I; Wurtele H; Masson JY; Zhu XD
Nucleic Acids Res; 2021 Dec; 49(22):12836-12854. PubMed ID: 34871413
[TBL] [Abstract][Full Text] [Related]
4. Replication fork stability confers chemoresistance in BRCA-deficient cells.
Ray Chaudhuri A; Callen E; Ding X; Gogola E; Duarte AA; Lee JE; Wong N; Lafarga V; Calvo JA; Panzarino NJ; John S; Day A; Crespo AV; Shen B; Starnes LM; de Ruiter JR; Daniel JA; Konstantinopoulos PA; Cortez D; Cantor SB; Fernandez-Capetillo O; Ge K; Jonkers J; Rottenberg S; Sharan SK; Nussenzweig A
Nature; 2016 Jul; 535(7612):382-7. PubMed ID: 27443740
[TBL] [Abstract][Full Text] [Related]
5. PCAF-Mediated Histone Acetylation Promotes Replication Fork Degradation by MRE11 and EXO1 in BRCA-Deficient Cells.
Kim JJ; Lee SY; Choi JH; Woo HG; Xhemalce B; Miller KM
Mol Cell; 2020 Oct; 80(2):327-344.e8. PubMed ID: 32966758
[TBL] [Abstract][Full Text] [Related]
6. Abro1 maintains genome stability and limits replication stress by protecting replication fork stability.
Xu S; Wu X; Wu L; Castillo A; Liu J; Atkinson E; Paul A; Su D; Schlacher K; Komatsu Y; You MJ; Wang B
Genes Dev; 2017 Jul; 31(14):1469-1482. PubMed ID: 28860160
[TBL] [Abstract][Full Text] [Related]
7. MRE11 and EXO1 nucleases degrade reversed forks and elicit MUS81-dependent fork rescue in BRCA2-deficient cells.
Lemaçon D; Jackson J; Quinet A; Brickner JR; Li S; Yazinski S; You Z; Ira G; Zou L; Mosammaparast N; Vindigni A
Nat Commun; 2017 Oct; 8(1):860. PubMed ID: 29038425
[TBL] [Abstract][Full Text] [Related]
8. EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation.
Rondinelli B; Gogola E; Yücel H; Duarte AA; van de Ven M; van der Sluijs R; Konstantinopoulos PA; Jonkers J; Ceccaldi R; Rottenberg S; D'Andrea AD
Nat Cell Biol; 2017 Nov; 19(11):1371-1378. PubMed ID: 29035360
[TBL] [Abstract][Full Text] [Related]
9. E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cells.
Duan H; Mansour S; Reed R; Gillis MK; Parent B; Liu B; Sztupinszki Z; Birkbak N; Szallasi Z; Elia AEH; Garber JE; Pathania S
J Cell Biol; 2020 Jun; 219(6):. PubMed ID: 32391871
[TBL] [Abstract][Full Text] [Related]
10. Class I Histone Deacetylase HDAC1 and WRN RECQ Helicase Contribute Additively to Protect Replication Forks upon Hydroxyurea-induced Arrest.
Kehrli K; Phelps M; Lazarchuk P; Chen E; Monnat R; Sidorova JM
J Biol Chem; 2016 Nov; 291(47):24487-24503. PubMed ID: 27672210
[TBL] [Abstract][Full Text] [Related]
11. Smarcal1-Mediated Fork Reversal Triggers Mre11-Dependent Degradation of Nascent DNA in the Absence of Brca2 and Stable Rad51 Nucleofilaments.
Kolinjivadi AM; Sannino V; De Antoni A; Zadorozhny K; Kilkenny M; Técher H; Baldi G; Shen R; Ciccia A; Pellegrini L; Krejci L; Costanzo V
Mol Cell; 2017 Sep; 67(5):867-881.e7. PubMed ID: 28757209
[TBL] [Abstract][Full Text] [Related]
12. Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1.
Ying S; Hamdy FC; Helleday T
Cancer Res; 2012 Jun; 72(11):2814-21. PubMed ID: 22447567
[TBL] [Abstract][Full Text] [Related]
13. CSB and SMARCAL1 compete for RPA32 at stalled forks and differentially control the fate of stalled forks in BRCA2-deficient cells.
Batenburg NL; Sowa DJ; Walker JR; Andres SN; Zhu XD
Nucleic Acids Res; 2024 May; 52(9):5067-5087. PubMed ID: 38416570
[TBL] [Abstract][Full Text] [Related]
14. Restoration of Replication Fork Stability in BRCA1- and BRCA2-Deficient Cells by Inactivation of SNF2-Family Fork Remodelers.
Taglialatela A; Alvarez S; Leuzzi G; Sannino V; Ranjha L; Huang JW; Madubata C; Anand R; Levy B; Rabadan R; Cejka P; Costanzo V; Ciccia A
Mol Cell; 2017 Oct; 68(2):414-430.e8. PubMed ID: 29053959
[TBL] [Abstract][Full Text] [Related]
15. DNA2 drives processing and restart of reversed replication forks in human cells.
Thangavel S; Berti M; Levikova M; Pinto C; Gomathinayagam S; Vujanovic M; Zellweger R; Moore H; Lee EH; Hendrickson EA; Cejka P; Stewart S; Lopes M; Vindigni A
J Cell Biol; 2015 Mar; 208(5):545-62. PubMed ID: 25733713
[TBL] [Abstract][Full Text] [Related]
16. Human CST complex protects stalled replication forks by directly blocking MRE11 degradation of nascent-strand DNA.
Lyu X; Lei KH; Biak Sang P; Shiva O; Chastain M; Chi P; Chai W
EMBO J; 2021 Jan; 40(2):e103654. PubMed ID: 33210317
[TBL] [Abstract][Full Text] [Related]
17. Replication fork reversal triggers fork degradation in BRCA2-defective cells.
Mijic S; Zellweger R; Chappidi N; Berti M; Jacobs K; Mutreja K; Ursich S; Ray Chaudhuri A; Nussenzweig A; Janscak P; Lopes M
Nat Commun; 2017 Oct; 8(1):859. PubMed ID: 29038466
[TBL] [Abstract][Full Text] [Related]
18. Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.
Kim TM; Son MY; Dodds S; Hu L; Hasty P
Mutat Res; 2014; 766-767():66-72. PubMed ID: 25847274
[TBL] [Abstract][Full Text] [Related]
19. Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11.
Schlacher K; Christ N; Siaud N; Egashira A; Wu H; Jasin M
Cell; 2011 May; 145(4):529-42. PubMed ID: 21565612
[TBL] [Abstract][Full Text] [Related]
20. Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies.
Ding X; Ray Chaudhuri A; Callen E; Pang Y; Biswas K; Klarmann KD; Martin BK; Burkett S; Cleveland L; Stauffer S; Sullivan T; Dewan A; Marks H; Tubbs AT; Wong N; Buehler E; Akagi K; Martin SE; Keller JR; Nussenzweig A; Sharan SK
Nat Commun; 2016 Aug; 7():12425. PubMed ID: 27498558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
